About Mass Spectrometry

Drug Discovery, Disease Evaluations & Omics Applications

Strategies for Quantitative Proteomics presented by M. Arthur Moseley (Duke University) on June 3, 2018.

Cancer Immunotherapy and Mass Spectrometry presented by Donald F. Hunt (University of Virginia) on June 4, 2017.

Metabolite Profiling at the 'Omic' Scale: Untargeted Does not Mean Unplanned presented by Gary Patti (Washington University, St. Louis) on May 31, 2015.

Mass Spectrometry in the Pharmaceutical Industry: Everything You Ever Wanted to Know but Were Afraid to Ask presented by Lucinda Hittle (Merck Research Laboratories) on June 14, 2014.

A Wide Spectrum:  Clinical Diagnostics for the Masses presented by Andy Hoofnagle (University of Washington) on June 9, 2013.

The Role of Mass Spectrometry in Drug Discovery and Development presented by Walter A. Korfmacher (Merck Research Labs) on May 23, 2010.